Lumos Pharma Investigational Site — Staten Island, New York

Lumos Pharma Investigational Site is a clinical research site located in Staten Island, New York, United States 10306.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Lumos Pharma Investigational Site has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Growth Hormone Deficiency (GHD).

Sponsors: Lumos Pharma.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lumos Pharma Investigational Site?

Lumos Pharma Investigational Site has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lumos Pharma Investigational Site conducted?

Lumos Pharma Investigational Site has 1 clinical trials on record, with 1 currently active. Their work covers Growth Hormone Deficiency (GHD).

Is Lumos Pharma Investigational Site accredited by Crixeo Health?

Lumos Pharma Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Lumos Pharma Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.